SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parmax Pharma submits intimation for reschedule of board meeting

15 Nov 2025 Evaluate
In continuation of corporate announcement dated November 07, 2025, Parmax Pharma has informed that the meeting of the Board of Directors of the Company which was supposed to be held on November 14, 2024, has been rescheduled on November 15, 2025 due to certain unavoidable reasons, unaudited financial results for quarter and half year ended on September 30, 2025 will be approved and considered at this meeting. 

The above information is a part of company’s filings submitted to BSE.

Parmax Pharma Share Price

32.99 1.29 (4.07%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×